TBR Commentary: CSC Maintained Its Focus on Developing Solutions Across Its Targeted Markets, Setting a Course For Growth - Sponsored Whitepaper

The future of CSC’s centerpiece healthcare engagement with the U.K. National Health Service remained uncertain during 1Q11. The prolonged negotiation and rescoping impacted CSC’s FY11 results by an estimated $100 million, and the effects are expected to push into FY12.

Immediately following the close of the quarter, CSC announced its acquisition of iSoft Group Limited of Australia, a solution provider in the NHS engagement. TBR believes the completion of the acquisition enables CSC to demonstrate additional implementation efficiencies and drive improvements within the NHS deal.